DE60038698D1 - Hydrogel-gesteuerte dosierungsform - Google Patents
Hydrogel-gesteuerte dosierungsformInfo
- Publication number
- DE60038698D1 DE60038698D1 DE60038698T DE60038698T DE60038698D1 DE 60038698 D1 DE60038698 D1 DE 60038698D1 DE 60038698 T DE60038698 T DE 60038698T DE 60038698 T DE60038698 T DE 60038698T DE 60038698 D1 DE60038698 D1 DE 60038698D1
- Authority
- DE
- Germany
- Prior art keywords
- hydrogel
- dosage form
- controlled dosage
- controlled
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17196899P | 1999-12-23 | 1999-12-23 | |
US171968P | 1999-12-23 | ||
PCT/IB2000/001920 WO2001047500A1 (en) | 1999-12-23 | 2000-12-20 | Hydrogel-driven drug dosage form |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60038698D1 true DE60038698D1 (de) | 2008-06-05 |
DE60038698T2 DE60038698T2 (de) | 2009-05-07 |
Family
ID=22625827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60038698T Expired - Lifetime DE60038698T2 (de) | 1999-12-23 | 2000-12-20 | Hydrogel-gesteuerte dosierungsform |
Country Status (42)
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY26615A1 (es) | 2000-03-16 | 2001-10-25 | Pfizer Prod Inc | Inhibidor de la glucogeno fosforilasa. |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
US20100196466A1 (en) * | 2000-06-06 | 2010-08-05 | Capricorn Pharma Inc. | Drug delivery system |
US7678387B2 (en) * | 2000-06-06 | 2010-03-16 | Capricorn Pharma, Inc. | Drug delivery systems |
US20070059367A1 (en) * | 2000-06-06 | 2007-03-15 | Cherukuri S R | Drug Delivery System and Associated Methods |
US7115279B2 (en) * | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
WO2003000226A2 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions containing polymer and drug assemblies |
WO2003004031A1 (en) | 2001-07-06 | 2003-01-16 | Endo Pharmaceuticals, Inc. | Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
ATE395044T1 (de) | 2002-02-01 | 2008-05-15 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien |
KR20040083493A (ko) * | 2002-02-01 | 2004-10-02 | 화이자 프로덕츠 인크. | 콜레스테릴 에스테르 전달 단백질 억제제의 제어 방출형제약상 제형 |
WO2003096968A2 (en) * | 2002-05-15 | 2003-11-27 | Sun Pharmaceutical Industries Limited | Oral osmotic controlled drug delivery system |
US20040076668A1 (en) * | 2002-07-03 | 2004-04-22 | Pfizer Inc. | Controlled-release pharmaceutical formulations |
WO2004050068A1 (en) | 2002-11-29 | 2004-06-17 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
EP1596837A2 (de) * | 2003-02-07 | 2005-11-23 | Omega Farma Ehf | Venlafaxin-formulierungen mit verzogerter freisetzung |
WO2004098572A1 (en) * | 2003-05-06 | 2004-11-18 | Ranbaxy Laboratories Limited | Biphasic release of glipizide from monocompartment osmotic dosage form |
ATE540671T1 (de) | 2003-08-04 | 2012-01-15 | Bend Res Inc | Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien |
US8377952B2 (en) * | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) * | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
CA2537413A1 (en) * | 2003-09-02 | 2005-03-10 | Imran Ahmed | Sustained release dosage forms of ziprasidone |
WO2006045152A1 (en) * | 2004-10-29 | 2006-05-04 | Mayne Pharma International Pty Ltd | Improved tabletting process |
WO2006072878A1 (en) * | 2005-01-07 | 2006-07-13 | Ranbaxy Laboratories Limited | Oral dosage forms of sertraline having controlled particle size and processes for their preparation |
GB0504547D0 (en) * | 2005-03-04 | 2005-04-13 | Delsol Products Ltd | Personal lubricant |
WO2006123364A2 (en) * | 2005-03-14 | 2006-11-23 | Sun Pharmaceutical Industries Limited | Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative |
US7919483B2 (en) * | 2005-06-24 | 2011-04-05 | Medicis Pharmaceutical Corporation | Method for the treatment of acne |
US7541347B2 (en) | 2007-04-02 | 2009-06-02 | Medicis Pharmaceutical Coropration | Minocycline oral dosage forms for the treatment of acne |
US8722650B1 (en) | 2005-06-24 | 2014-05-13 | Medicis Pharmaceutical Corporation | Extended-release minocycline dosage forms |
US20080241235A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US8252776B2 (en) | 2007-04-02 | 2012-08-28 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US7544373B2 (en) * | 2007-04-02 | 2009-06-09 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US20080242642A1 (en) | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
WO2007057762A2 (en) * | 2005-11-16 | 2007-05-24 | Pfizer Limited | Osmotic bi-layer tablet |
US20080241197A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline dosage forms for the treatment of acne |
CN101439026B (zh) * | 2007-11-23 | 2011-04-06 | 北京红林制药有限公司 | 含有多沙唑嗪或其盐的控释制剂及其制备方法 |
MX2010008861A (es) * | 2008-02-15 | 2011-02-22 | Sun Pharma Advanced Res Co Ltd | Tableta oral de liberacion controlada con efecto de liberacion masiva reducido. |
WO2010017310A1 (en) | 2008-08-06 | 2010-02-11 | Medicis Pharmaceutical Corporation | Method for the treatment of acne and certain dosage forms thereof |
KR101004205B1 (ko) | 2008-12-17 | 2010-12-24 | 동아제약주식회사 | 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 |
KR101284368B1 (ko) | 2010-07-09 | 2013-07-15 | 서울대학교산학협력단 | 나노섬유시트 기재의 경구용 약물의 제어 전달을 위한 시스템 |
WO2012103411A2 (en) * | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
US9561241B1 (en) | 2011-06-28 | 2017-02-07 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for minocycline |
US9918937B2 (en) * | 2013-01-30 | 2018-03-20 | Daewoong Co., Ltd. | Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract |
MX2015012416A (es) * | 2013-03-14 | 2016-04-07 | Amgen Inc | Compuestos heterociclicos y sus usos. |
CA2902646C (en) | 2013-03-14 | 2022-08-16 | Cytokinetics, Inc. | Heterocyclic compounds and their uses |
US20170182070A1 (en) | 2014-10-08 | 2017-06-29 | Mayne Pharma International Pty Ltd. | Controlled Release Doxycycline |
AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
WO2017035408A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
RU2018145364A (ru) | 2016-06-27 | 2020-07-28 | Ачиллион Фармасьютикалс, Инк. | Хиназолиновые и индольные соединения для лечения медицинских нарушений |
EP3841086A4 (de) | 2018-08-20 | 2022-07-27 | Achillion Pharmaceuticals, Inc. | Pharmazeutische zusammensetzungen zur behandlung von medizinischen störungen im zusammenhang mit komplementfaktor d |
CN113365617A (zh) | 2018-10-16 | 2021-09-07 | 乔治亚州立大学研究基金会股份有限公司 | 用于医学疾病治疗的一氧化碳前药 |
CN115768410A (zh) * | 2020-07-10 | 2023-03-07 | 阿代尔制药股份有限公司 | 可溶胀的口服药物组合物 |
IL301389A (en) | 2020-09-18 | 2023-05-01 | Bristol Myers Squibb Co | Dosage forms for TYK2 inhibitors that include swellable cores |
TW202325285A (zh) * | 2021-10-14 | 2023-07-01 | 靜岡縣公立大學法人 | 粉末製劑 |
WO2023154171A1 (en) * | 2022-02-14 | 2023-08-17 | Purdue Research Foundation | Polymer salts for improved drug delivery from amorphous solid dispersions |
Family Cites Families (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US5366738A (en) * | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
IT1165797B (it) * | 1982-10-18 | 1987-04-29 | Consiglio Nazionale Ricerche | Procedimento di preparazione di alchilangelicine esenti da psoraleni ed alchilangolicine ottenute col procedimento |
US4765989A (en) * | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
US5082668A (en) * | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
GB8322007D0 (en) * | 1983-08-16 | 1983-09-21 | Wellcome Found | Pharmaceutical delivery system |
US4624848A (en) * | 1984-05-10 | 1986-11-25 | Ciba-Geigy Corporation | Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use |
US4968507A (en) * | 1984-06-20 | 1990-11-06 | Merck & Co., Inc. | Controlled porosity osmotic pump |
US4624847A (en) * | 1985-04-22 | 1986-11-25 | Alza Corporation | Drug delivery device for programmed delivery of beneficial drug |
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
US4865598A (en) * | 1985-08-16 | 1989-09-12 | Alza Corporation | Dispensing system for administering beneficial agent |
EP0277092B1 (de) * | 1987-01-14 | 1992-01-29 | Ciba-Geigy Ag | Therapeutisches System für schwerlösliche Wirkstoffe |
US4851232A (en) | 1987-02-13 | 1989-07-25 | Alza Corporation | Drug delivery system with means for obtaining desirable in vivo release rate pattern |
US4795641A (en) * | 1987-08-20 | 1989-01-03 | Eastman Kodak Company | Polymer blends having reverse phase morphology for controlled delivery of bioactive agents |
US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
US5096716A (en) * | 1988-09-01 | 1992-03-17 | Alza Corporation | Dosage form for administering calcium antagonist nicardipine |
US5034229A (en) * | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog |
US5110596A (en) * | 1988-12-13 | 1992-05-05 | Alza Corporation | Delivery system comprising means for delivering agent to livestock |
IL92966A (en) * | 1989-01-12 | 1995-07-31 | Pfizer | Hydrogel-operated release devices |
US5186942A (en) * | 1989-01-30 | 1993-02-16 | Alza Corporation | Nicardipine therapy |
DD295760A5 (de) * | 1989-01-31 | 1991-11-14 | Martin-Luther-Universitaet Halle Wittenberg,De | Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung |
US5019396A (en) * | 1989-05-12 | 1991-05-28 | Alza Corporation | Delivery dispenser for treating cardiac arrhythmias |
US5776493A (en) * | 1989-07-14 | 1998-07-07 | Alza Corporation | Oral osmotic device for delivery of nystatin with hydrogel driving member |
US5273752A (en) * | 1989-07-18 | 1993-12-28 | Alza Corporation | Controlled release dispenser comprising beneficial agent |
US5126142A (en) * | 1989-07-18 | 1992-06-30 | Alza Corporation | Dispenser comprising ionophore |
US5091190A (en) * | 1989-09-05 | 1992-02-25 | Alza Corporation | Delivery system for administration blood-glucose lowering drug |
US5035897A (en) * | 1989-09-05 | 1991-07-30 | Alza Corporation | Dosage form for delivering soluble or insoluble drugs |
US5120548A (en) * | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5200197A (en) * | 1989-11-16 | 1993-04-06 | Alza Corporation | Contraceptive pill |
US5151450A (en) * | 1990-02-22 | 1992-09-29 | Tokyo Tanabe Company, Limited | Antiulcer substance |
US5192550A (en) * | 1990-05-07 | 1993-03-09 | Alza Corporation | Dosage form for treating central nervous system disorders |
US5190763A (en) * | 1990-05-07 | 1993-03-02 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5221536A (en) * | 1990-05-07 | 1993-06-22 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
US5128145A (en) * | 1990-06-13 | 1992-07-07 | Alza Corporation | Dosage form for Parkinson's disease, spasticity and muscle spasms |
JP2558396B2 (ja) * | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
DK0550641T3 (da) * | 1990-09-28 | 1994-08-22 | Pfizer | Dispenseringsanordning indeholdende et hydrofobt medium |
US5160744A (en) * | 1991-06-27 | 1992-11-03 | Alza Corporation | Verapmil therapy |
PT100944B (pt) * | 1991-10-10 | 2000-02-29 | Alza Corp | Dispositivo para o fornecimento osmotico de farmacos com paredes de materiais hidrofobicos |
US5200195A (en) * | 1991-12-06 | 1993-04-06 | Alza Corporation | Process for improving dosage form delivery kinetics |
US5185158A (en) * | 1992-02-27 | 1993-02-09 | Alza Corporation | Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same |
JP3140465B2 (ja) * | 1992-09-18 | 2001-03-05 | 山之内製薬株式会社 | ハイドロゲル徐放性製剤 |
US5358721A (en) * | 1992-12-04 | 1994-10-25 | Alza Corporation | Antiviral therapy |
EP0621032B1 (de) * | 1993-04-23 | 2000-08-09 | Novartis AG | Wirkstoffabgabevorrichtung mit gesteuerter Freigabe |
US6287598B1 (en) * | 1993-05-28 | 2001-09-11 | Alza Corporation | Method for providing sustained antiepileptic therapy |
HU213407B (en) * | 1993-12-09 | 1997-06-30 | Egyt Gyogyszervegyeszeti Gyar | Process for producing tablet with diffusive-osmotic release |
GB9326267D0 (en) * | 1993-12-23 | 1994-02-23 | Scherer Corp R P | Expulsion of material |
US5458887A (en) * | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
US5458888A (en) * | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
KR100232297B1 (ko) * | 1994-05-06 | 1999-12-01 | 디. 제이. 우드 | 아지트로마이신의 제어된 방출 투여형 제제 |
US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
US5529787A (en) * | 1994-07-07 | 1996-06-25 | Alza Corporation | Hydromorphone therapy |
US5582591A (en) * | 1994-09-02 | 1996-12-10 | Delab | Delivery of solid drug compositions |
US5718700A (en) * | 1994-09-20 | 1998-02-17 | Alza Corporation | Exit means in dosage form |
US5614578A (en) * | 1994-10-28 | 1997-03-25 | Alza Corporation | Injection-molded dosage form |
US5607696A (en) * | 1995-02-10 | 1997-03-04 | Alza Corporation | Osmotic membrane and delivery device |
US5736159A (en) * | 1995-04-28 | 1998-04-07 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water insoluble drugs in which a passageway is formed in situ |
US5817335A (en) * | 1995-05-26 | 1998-10-06 | Alza Corporation | Osmotic device with high drug loading and delayed activation of drug delivery |
US5654005A (en) * | 1995-06-07 | 1997-08-05 | Andrx Pharmaceuticals, Inc. | Controlled release formulation having a preformed passageway |
US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
FR2744733B1 (fr) * | 1996-02-08 | 1998-04-24 | Ascometal Sa | Acier pour la fabrication de piece forgee et procede de fabrication d'une piece forgee |
IT1290764B1 (it) * | 1996-05-03 | 1998-12-10 | Vevy Europ S P A | Pentapeptide per la preparazione di composizioni dermo- farmaceutiche e cosmetiche per il trattamento di lesioni od affezioni cutanee |
US5837379A (en) * | 1997-01-31 | 1998-11-17 | Andrx Pharmaceuticals, Inc. | Once daily pharmaceutical tablet having a unitary core |
US6271278B1 (en) * | 1997-05-13 | 2001-08-07 | Purdue Research Foundation | Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties |
EP0914098B1 (de) * | 1997-05-30 | 2003-10-01 | Osmotica Corp. | Mehrlagige osmosevorrichtung |
ES2287971T3 (es) * | 1997-08-11 | 2007-12-16 | Pfizer Products Inc. | Dispersiones farmaceuticas solidas con biodisponibilidad incrementada. |
DE19737463A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
US6037346A (en) * | 1997-10-28 | 2000-03-14 | Vivus, Inc. | Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
US6706283B1 (en) | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
ATE433318T1 (de) * | 1999-02-10 | 2009-06-15 | Pfizer Prod Inc | Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten |
US6245200B1 (en) | 1999-12-10 | 2001-06-12 | Sandia Corporation | Photo-oxidation method using MoS2 nanocluster materials |
WO2001047498A2 (en) * | 1999-12-23 | 2001-07-05 | Pfizer Products Inc. | Hydrogel-driven layered drug dosage form comprising sertraline |
US20030086972A1 (en) * | 2000-08-09 | 2003-05-08 | Appel Leah E. | Hydrogel-driven drug dosage form |
-
2000
- 2000-12-20 SI SI200030997T patent/SI1242055T1/sl unknown
- 2000-12-20 EP EP08154885A patent/EP1967185A1/de not_active Withdrawn
- 2000-12-20 OA OA1200200195A patent/OA12128A/en unknown
- 2000-12-20 KR KR10-2002-7008223A patent/KR100523127B1/ko not_active IP Right Cessation
- 2000-12-20 AU AU20189/01A patent/AU783685B2/en not_active Ceased
- 2000-12-20 CZ CZ20022046A patent/CZ20022046A3/cs unknown
- 2000-12-20 PL PL00357535A patent/PL357535A1/xx not_active Application Discontinuation
- 2000-12-20 EE EEP200200361A patent/EE200200361A/xx unknown
- 2000-12-20 YU YU35302A patent/YU35302A/sh unknown
- 2000-12-20 HU HU0301242A patent/HUP0301242A3/hu unknown
- 2000-12-20 DZ DZ003228A patent/DZ3228A1/fr active
- 2000-12-20 IL IL14922400A patent/IL149224A0/xx unknown
- 2000-12-20 AP APAP/P/2002/002553A patent/AP2002002553A0/en unknown
- 2000-12-20 JP JP2001548095A patent/JP4100910B2/ja not_active Expired - Fee Related
- 2000-12-20 EP EP00983435A patent/EP1242055B1/de not_active Expired - Lifetime
- 2000-12-20 US US09/745,095 patent/US20020015731A1/en not_active Abandoned
- 2000-12-20 CN CN00816441A patent/CN1402632A/zh active Pending
- 2000-12-20 AT AT00983435T patent/ATE392890T1/de not_active IP Right Cessation
- 2000-12-20 PT PT00983435T patent/PT1242055E/pt unknown
- 2000-12-20 WO PCT/IB2000/001920 patent/WO2001047500A1/en active IP Right Grant
- 2000-12-20 CA CA002395333A patent/CA2395333C/en not_active Expired - Fee Related
- 2000-12-20 DK DK00983435T patent/DK1242055T3/da active
- 2000-12-20 DE DE60038698T patent/DE60038698T2/de not_active Expired - Lifetime
- 2000-12-20 ES ES00983435T patent/ES2302705T3/es not_active Expired - Lifetime
- 2000-12-20 SK SK857-2002A patent/SK8572002A3/sk unknown
- 2000-12-20 TR TR2002/01646T patent/TR200201646T2/xx unknown
- 2000-12-20 BR BR0016708-8A patent/BR0016708A/pt not_active Application Discontinuation
- 2000-12-20 MX MXPA02006328A patent/MXPA02006328A/es active IP Right Grant
- 2000-12-20 GE GE4830A patent/GEP20043334B/en unknown
- 2000-12-20 NZ NZ518281A patent/NZ518281A/en unknown
- 2000-12-20 EA EA200200595A patent/EA004370B1/ru not_active IP Right Cessation
- 2000-12-21 GT GT200000222A patent/GT200000222A/es unknown
- 2000-12-22 TN TNTNSN00253A patent/TNSN00253A1/fr unknown
- 2000-12-22 PA PA20008509001A patent/PA8509001A1/es unknown
- 2000-12-22 SV SV2000000250A patent/SV2002000250A/es unknown
- 2000-12-22 AR ARP000106897A patent/AR027091A1/es unknown
- 2000-12-22 PE PE2000001391A patent/PE20010985A1/es not_active Application Discontinuation
-
2002
- 2002-04-12 IS IS6340A patent/IS6340A/is unknown
- 2002-06-04 CR CR6656A patent/CR6656A/es unknown
- 2002-06-18 MA MA26695A patent/MA26859A1/fr unknown
- 2002-06-20 NO NO20022970A patent/NO20022970D0/no not_active Application Discontinuation
- 2002-06-20 ZA ZA200204960A patent/ZA200204960B/en unknown
- 2002-06-24 BG BG106865A patent/BG106865A/bg unknown
-
2006
- 2006-12-14 US US11/610,603 patent/US20070087057A1/en not_active Abandoned
-
2010
- 2010-12-27 US US12/979,278 patent/US9028870B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60038698D1 (de) | Hydrogel-gesteuerte dosierungsform | |
IS6686A (is) | Hýdrógel-drifið lyfjaskömmtunarform | |
NO20015175L (no) | Farmasöytisk sammensetning | |
DE122007000064I1 (de) | Erythropoietinkonjugate | |
DE19983871T1 (de) | Fönvorrichtung | |
DE10084676T1 (de) | Einmallanzettvorrichtung | |
ATA51899A (de) | Handstempel | |
ATE357433T1 (de) | 4-pyrimidinyl-n-acyl-l-phenylanine | |
NO992692L (no) | Nefadozon doseringsform | |
EE200200150A (et) | Preparaat | |
ATE297895T1 (de) | 4-pyridinyl-n-acyl-l-phenylalanine | |
NO20022606D0 (no) | Farmasöytiske kombinasjoner | |
NO20014926D0 (no) | Farmasöytiske forbindelser | |
DE50000805D1 (de) | Aufsitzspanner | |
FI4488U1 (fi) | Farmaseuttinen koostumus | |
DE10085008T1 (de) | Oberflächenbehandlungsdüse | |
IS6163A (is) | Lyfjakomplex | |
DE19983890T1 (de) | Ventiltaktgebungsjustiereinrichtung | |
DE10082008D2 (de) | Ausbeulgerät | |
ATE269311T1 (de) | Benzoylpyridazine | |
ATE440824T1 (de) | Nitro-sulfobenzamide | |
ATA107599A (de) | Heizwasserbereiter | |
DE10085167T1 (de) | Gangumschalteinrichtung | |
AT500658A3 (de) | Isolierplatte | |
DE29900278U1 (de) | Biobeton |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |